GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vaso Corporation (OTCPK:VASO) » Definitions » Cyclically Adjusted PS Ratio

Vaso (VASO) Cyclically Adjusted PS Ratio : 0.48 (As of Jun. 06, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Vaso Cyclically Adjusted PS Ratio?

As of today (2024-06-06), Vaso's current share price is $0.24174. Vaso's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.50. Vaso's Cyclically Adjusted PS Ratio for today is 0.48.

The historical rank and industry rank for Vaso's Cyclically Adjusted PS Ratio or its related term are showing as below:

VASO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.03   Med: 0.44   Max: 2.65
Current: 0.5

During the past years, Vaso's highest Cyclically Adjusted PS Ratio was 2.65. The lowest was 0.03. And the median was 0.44.

VASO's Cyclically Adjusted PS Ratio is ranked better than
73.18% of 343 companies
in the Healthcare Providers & Services industry
Industry Median: 1.23 vs VASO: 0.50

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vaso's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.107. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.50 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Vaso Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Vaso's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaso Cyclically Adjusted PS Ratio Chart

Vaso Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.25 0.13 0.36 0.62

Vaso Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.52 0.69 0.62 0.60

Competitive Comparison of Vaso's Cyclically Adjusted PS Ratio

For the Health Information Services subindustry, Vaso's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaso's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vaso's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vaso's Cyclically Adjusted PS Ratio falls into.



Vaso Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Vaso's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.24174/0.5
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaso's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Vaso's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.107/131.7762*131.7762
=0.107

Current CPI (Mar. 2024) = 131.7762.

Vaso Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.051 100.560 0.067
201409 0.049 100.428 0.064
201412 0.078 99.070 0.104
201503 0.048 99.621 0.063
201506 0.069 100.684 0.090
201509 0.110 100.392 0.144
201512 0.135 99.792 0.178
201603 0.111 100.470 0.146
201606 0.115 101.688 0.149
201609 0.109 101.861 0.141
201612 0.120 101.863 0.155
201703 0.102 102.862 0.131
201706 0.110 103.349 0.140
201709 0.110 104.136 0.139
201712 0.126 104.011 0.160
201803 0.107 105.290 0.134
201806 0.112 106.317 0.139
201809 0.113 106.507 0.140
201812 0.115 105.998 0.143
201903 0.093 107.251 0.114
201906 0.105 108.070 0.128
201909 0.111 108.329 0.135
201912 0.141 108.420 0.171
202003 0.102 108.902 0.123
202006 0.096 108.767 0.116
202009 0.102 109.815 0.122
202012 0.108 109.897 0.130
202103 0.097 111.754 0.114
202106 0.093 114.631 0.107
202109 0.106 115.734 0.121
202112 0.140 117.630 0.157
202203 0.099 121.301 0.108
202206 0.112 125.017 0.118
202209 0.113 125.227 0.119
202212 0.133 125.222 0.140
202303 0.109 127.348 0.113
202306 0.117 128.729 0.120
202309 0.111 129.860 0.113
202312 0.125 129.419 0.127
202403 0.107 131.776 0.107

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vaso  (OTCPK:VASO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Vaso Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Vaso's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaso (VASO) Business Description

Traded in Other Exchanges
N/A
Address
137 Commercial Street, Unit 200, Plainview, NY, USA, 11803
Vaso Corporation is a medical technology company. It provides diverse product and service categories, including noninvasive monitoring and therapeutic devices, diagnostic imaging equipment, and information technology for enterprises and clinical customers. The company currently operates in three distinct business units namely IT; Professional sales and Equipment. It generates maximum revenue from the IT segment. IT segment focuses on healthcare IT and managed network technology services.
Executives
Leon Dembo director 137 COMMERCIAL STREET, SUITE 200, PLAINVIEW NY 11803
Janey Moen director 137 COMMERCIAL STREET, SUITE 200, PLAINVIEW NY 11803
Jun Ma director C/O VASOMEDICAL, INC., 180 LINDEN AVENUE, WESTBURY NY 11590
Edgar Rios director 1650 TYSONS BOULEVARD, SUITE 900, MCLEAN VA 22102
Michael Beecher officer: Chief Financial Officer C/O DIRECT INSITE CORP, 80 ORVILLE DRIVE, BOHEMIA NY 11716
Joshua Markowitz director 3131 PRINCETON PIKE, BLDG. 3D, SUITE 200, LAWRENCEVILLE NJ 08648
Jonathan P Newton officer: Vice Pres Finance & Controller 152 RICHMOND AVENUE, AMITYVILLE NY 11701
Peter C Castle director C/O NETWOLVES CORP, 4002 EISENHOWER BLVD, TEMPA FL 33634
David H Lieberman director 3061 INDUSTRY DR, LANCASTER PA 17603
Behnam Movaseghi director C/O KERNS MANUFACTURING CORPORATION, 37-14 29TH STREET, LONG ISLAND CITY NY 11101
Nelson Randall Hill officer: Senior Vice President 3880 EAST COUNTY HIGHWAY 30A, UNIT 201, SANTA ROSA BEACH FL 24159
William Edward Dempsey director 52 PARK AVENUE, SANDYMOUNT L2 DUBLIN 4
David Tarachand Singh officer: Chief Financial Officer C/O VASOMEDICAL, INC., 180 LINDEN AVENUE, WESTBURY NY 11590
Joseph Giacalone director
Derek Enlander director 88C UNION AVENUE, CENTER MORICHES NY 11934